Literature DB >> 33514065

Complete Androgen Insensitivity Syndrome: From Bench to Bed.

Nina Tyutyusheva1, Ilaria Mancini2, Giampiero Igli Baroncelli1, Sofia D'Elios1, Diego Peroni1, Maria Cristina Meriggiola2, Silvano Bertelloni1.   

Abstract

Complete androgen insensitivity syndrome (CAIS) is due to complete resistance to the action of androgens, determining a female phenotype in persons with a 46,XY karyotype and functioning testes. CAIS is caused by inactivating mutations in the androgen receptor gene (AR). It is organized in eight exons located on the X chromosome. Hundreds of genetic variants in the AR gene have been reported in CAIS. They are distributed throughout the gene with a preponderance located in the ligand-binding domain. CAIS mainly presents as primary amenorrhea in an adolescent female or as a bilateral inguinal/labial hernia containing testes in prepubertal children. Some issues regarding the management of females with CAIS remain poorly standardized (such as the follow-up of intact testes, the timing of gonadal removal and optimal hormone replacement therapy). Basic research will lead to the consideration of new issues to improve long-term well-being (such as bone health, immune and metabolic aspects and cardiovascular risk). An expert multidisciplinary approach is mandatory to increase the long-term quality of life of women with CAIS.

Entities:  

Keywords:  AR gene; androgen receptor; bone health; complete androgen insensitivity syndrome; gonadal neoplasia; gonadal removal; hormonal substitutive therapy

Year:  2021        PMID: 33514065     DOI: 10.3390/ijms22031264

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  5 in total

1.  Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline.

Authors:  A Nordenström; S F Ahmed; E van den Akker; J Blair; M Bonomi; C Brachet; L H A Broersen; H L Claahsen-van der Grinten; A B Dessens; A Gawlik; C H Gravholt; A Juul; C Krausz; T Raivio; A Smyth; P Touraine; D Vitali; O M Dekkers
Journal:  Eur J Endocrinol       Date:  2022-04-21       Impact factor: 6.558

2.  Cytochrome P450 family 17 subfamily A member 1 mutation causes severe pseudohermaphroditism: A case report.

Authors:  Yu Gong; Fang Qin; Wen-Jia Li; Le-Yu Li; Ping He; Xing-Jian Zhou
Journal:  World J Clin Cases       Date:  2022-04-16       Impact factor: 1.534

3.  Complete Androgen Insensitivity Syndrome: From the Relevance of an Accurate Genetic Diagnosis to the Challenge of Clinical Management. A Case Report.

Authors:  Federica Barbagallo; Rossella Cannarella; Matteo Bertelli; Andrea Crafa; Sandro La Vignera; Rosita A Condorelli; Aldo E Calogero
Journal:  Medicina (Kaunas)       Date:  2021-10-21       Impact factor: 2.430

4.  Identification of Potential Genes in Pathogenesis and Diagnostic Value Analysis of Partial Androgen Insensitivity Syndrome Using Bioinformatics Analysis.

Authors:  Yajie Peng; Hui Zhu; Bing Han; Yue Xu; Xuemeng Liu; Huaidong Song; Jie Qiao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-18       Impact factor: 5.555

5.  Complete androgen insensitivity syndrome caused by the c.2678C>T mutation in the androgen receptor gene: A case report.

Authors:  Ka-Na Wang; Qing-Qing Chen; Yi-Lin Zhu; Chun-Lin Wang
Journal:  World J Clin Cases       Date:  2021-12-16       Impact factor: 1.337

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.